Tatsuya Kodama
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Amikacin exposure and its association with ototoxicity and efficacy in nontuberculous mycobacterial pulmonary disease treatment.
Journal: Respiratory medicine
Published: September 01, 2025
Prognosis of patients with bronchiectasis receiving long-term oxygen therapy.
Journal: Respiratory medicine
Published: August 14, 2025
Real-world effectiveness and lung abnormalities associated with amikacin liposome inhalation suspension.
Journal: Respiratory medicine
Published: April 28, 2025
Quantifying the Reversibility of Clofazimine-induced Pigmentation in a Patient with Mycobacterium abscessus Pulmonary Disease.
Journal: Internal medicine (Tokyo, Japan)
Published: November 20, 2024
Risk factors, molecular analysis and treatment outcomes of amikacin-resistant Mycobacterium avium complex pulmonary disease.
Journal: ERJ open research
Published: October 20, 2024
Epidemiological trends and clinical relevance of nontuberculous mycobacterial pulmonary disease in a referral hospital in Japan, 2017-2021.
Journal: Respiratory investigation
Published: July 20, 2024
Beyond Symptoms: Radiologic identification of asymptomatic Mycobacterium avium complex pulmonary infections.
Journal: Respiratory medicine
Published: January 31, 2024
A case of tuberculous pericarditis with cardiac tamponade due to a paradoxical response during treatment with anti-tuberculosis drugs.
Journal: IDCases
Published: November 28, 2023
Multiple bacterial culture positivity reflects the severity and prognosis as bronchiectasis in Mycobacterium avium complex pulmonary disease.
Journal: Respiratory medicine
Published: April 25, 2023
Characteristics of pleural effusion due to paradoxical response in patients with pulmonary tuberculosis.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: March 01, 2023
Last Updated: 09/26/2026